Journal: bioRxiv
Article Title: TIM3 + Tumor Associated M2 Macrophages Impair Antitumor T Cell Immunity and Promote Gastric Cancer Progression and Peritoneal Metastasis
doi: 10.64898/2026.04.15.716939
Figure Lengend Snippet: A. Violin plot showing TIM3 expression across all cell types from scRNA-seq analysis of unfractionated live cells from 20 GCPM samples. B . Multi-parameter flow cytometric analysis of TIM3 and its ligands Gal-9 and CEACAM1 across different cell types in 54 GCPM samples (see Supplemental Table 1). C . CyTOF analysis of TIM3, Gal-9, and immune markers in six GCPM samples, using cytokeratin, CD45, CD34, and CD68 to define epithelial and immune populations, as described in Methods. D . Strong positive correlations between TIM3 and CD163 (R = 0.94, P = 1.4 × 10□¹□) and between TIM3 and Gal-9 (R = 0.87, P = 1 × 10□¹²), validated by scRNA-seq analysis. E . Positive correlations between TIM3 and M2 macrophage markers CD163 and CSF1R in GC tissues, analyzed using the GEPIA database. F . Representative co-immunofluorescence staining of TIM3 and CD163 in five GCPM samples. Scale bar, 20 μm. G . Schematic illustrating macrophage polarization from U937 monocytes to an M1 state followed by repolarization to an M2 state using GA0518 tumor cell–conditioned medium. H . qRT-PCR analysis of TIM3, Gal-9, and M2-associated markers (CCL2 and IL10) in U937-derived M1 and M2 macrophages. P values are indicated.
Article Snippet: Human monocyte U937 and murine macrophage RAW264.7 were purchased from ATCC, and both monocytes and macrophages were cultured in 7% FBS-RPMI.
Techniques: Expressing, Immunofluorescence, Staining, Quantitative RT-PCR, Derivative Assay